Gross, John D.

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing

Gordon, D. E., Jang, G. M., Bouhaddou, M., Xu, J., Obernier, K., White, K. M., O’Meara, M. J., Rezelj, V. V., Guo, J. Z., Swaney, D. L., et al. (2020) · Nature

SARS-CoV-2 and COVID-19 ResearchComputational Drug Discovery Methods

Cited by 4,405

Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infection

Jäger, S., Kim, D. Y., Hultquist, J. F., Shindo, K., LaRue, R. S., Kwon, E., Li, M., Anderson, B. D., Yen, L., Stanley, D., et al. (2012) · Nature

HIV Research and TreatmentHIV/AIDS drug development and treatment

Cited by 352

Structural and molecular mechanisms for the control of eukaryotic 5′–3′ mRNA decay

Mugridge, J. S., Coller, J., & Gross, J. D. (2018) · Nature Structural & Molecular Biology

RNA Research and SplicingRNA and protein synthesis mechanisms

Cited by 133